The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study

被引:9
|
作者
Alrasheedi, Ahmad A. [1 ]
机构
[1] Qassim Univ, Dept Family & Community Med, Buraydah, Saudi Arabia
关键词
median age; vaccine; testing; european union; europe; covid-19; coronavirus; case-fatality; SARS-COV-2;
D O I
10.7759/cureus.33546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The world has been affected differently by the coronavirus disease 2019 (COVID-19), and Europe reaped the largest number of cases and deaths. Moreover, COVID-19 statistics are dynamic. Objectives The current study aimed to use COVID-19 data to examine the COVID-19 prevalence in Europe by the end of November 2022 and compare the findings globally. Methods The primary data on COVID-19 for each European country were obtained from the "Worldometer" website. The data include the cumulative incidence of COVID-19 per country, the cumulative number of deaths, the total number of tests performed, the number of cases per million population, the number of deaths per million, the number of tests per million, and the total population. The case-fatality rate was calculated (number of deaths/number of cases). In addition, the median age and the vaccination coverage rate (people who received two doses) for each European country were extracted from the "United Nations" website and the "Our World in Data" website, respectively. To compare European countries to the globe, COVID-19 data for each continent were obtained. The analysis of variance (ANOVA) test was used to compare variances across the means of the four parts of Europe based on the geographic division. An independent sample t-test was also used to compare the means between the European Union (EU) states and non-EU states. The Spearman correlation coefficient was used to determine the relationship between different variables across Europe. Results As of December 1, 2022, about 648 million COVID-19 cases and 6.6 million deaths have been recorded worldwide. Europe accounted for nearly 36.8% and 29.5% of all cases and deaths, respectively. Based on the number of deaths per million, Europe was the most affected continent after South America. Nearly 6.8 billion tests have been conducted worldwide, 41% done in Europe; 43 European countries have performed tests more than their population. However, COVID-19 statistics were inconsistent across the four parts of Europe. A significant difference was noticed between Eastern Europe and others, especially Northern Europe and Western Europe. By affiliation with the EU, there was no significant difference. For global comparison, the mean deaths per million, the mean cases per million, and the mean tests per population for European countries were higher than those of the world's countries, although they recorded a lower mean case-fatality rate (CFR). Thirteen European countries were among the 15 most affected countries worldwide based on the number of deaths per million, most located in Eastern and Southern Europe. The number of cases and the number of deaths were significantly proportional to the number of tests performed. Conclusions By the end of November 2022, Europe had the most cases of COVID-19, the most deaths, and the most tests performed, even though it accounts for 9.4% of the world's population. However, COVID-19 data were inconsistent across the four parts of Europe, especially between Eastern Europe and others. Given the natural immunity acquired during the three years and the excellent vaccine coverage in Europe, it is essential to reconsider the definition of a suspected case and establish more specific criteria for testing.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Analysis of COVID-19 Prevalence in Africa Based on the Geographic Division and Income by the End of 2022: A Cross-Sectional Study
    Alrasheedi, Ahmad Ali
    BAHRAIN MEDICAL BULLETIN, 2023, 45 (03) : 1632 - 1639
  • [2] COVID-19 Statistics in the Arab World by the End of October 2022: A Cross-Sectional Study
    Alrasheedi, Ahmad A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [3] Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022
    Rivadeneira, Josue
    Fuenmayor-Gonzalez, Luis
    Jacome-Garcia, Michelle
    Flores-Lastra, Nancy
    Delgado, Hugo
    Otzen, Tamara
    ATENCION PRIMARIA, 2025, 57 (04):
  • [4] Cross-Sectional Study of Prevalence of COVID-19 in Alkharj, Saudi Arabia
    Ahmed, Nehad J.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (20) : 184 - 188
  • [5] Comparison of COVID-19 Outcomes With Alpha-1 Antitrypsin Deficiency Prevalence in Europe: A Cross-Sectional Study
    Sezgin, Yilmaz
    Becel, Sinan
    Kaplan, Askin K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [6] Prevalence of COVID-19 in Bangladesh, April to October 2020 -a cross-sectional study
    Nazneena, Arifa
    Sultana, Rebeca
    Rahman, Mahmudur
    Rahman, Mahbubur
    Qadria, Firdausi
    Rimia, Nadia Ali
    Hossain, Md. Kamal
    Alama, Muhammad Rashedul
    Rahmana, Mustafizur
    Chakraborty, Nitai
    Sumon, Shariful Amin
    Hussain, Enayet
    Hassan, Md Zakiul
    Khana, Sazzad Hossain
    Prodhana, Md. Hasnatuzzaman
    Bablua, Arifur Rahman
    Banika, Kajal Chandra
    Fahad, Md. Habibullah
    Akhtar, Marjahan
    Satter, Syed Moinuddin
    Ahmed, Shahriar
    Rahmana, Ahmed Ehsanur
    Bhuiyan, Taufiqur Rahman
    Alamgir, A. S. M.
    El Arifeen, Shams
    Shirin, Tahmina
    Banu, Sayera
    Flora, Meerjady Sabrina
    IJID REGIONS, 2021, 1 : 92 - 99
  • [7] Prevalence of Parosmia among COVID-19 Patients in KSA: A Cross-Sectional Study
    Murad, Manal
    Abousada, Hoda Jehad
    Almalki, Raad Mohmmad A.
    Basrawi, Duaa Jihad
    Al Askar, Waleed Talae
    Bredy, Ghada Ibraheem
    Abdulghani, Sarh Sami
    Alhuthayli, Reema Sulaiman
    Alshehri, Wejdan Hezam
    Mugharbel, Abdulaziz Hatim
    Alahmari, Asma Moghram
    Asiri, Zayed Mofareh A.
    Alhazmi, Saja Dakheellah
    Altayb, Halah Mohammed
    Youldash, Omar Adnan
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (01): : 265 - 270
  • [8] Prevalence and Predictive Factors of Rhabdomyolysis in COVID-19 Patients: A Cross-sectional Study
    Hashemi, Behrooz
    Farhangi, Nader
    Toloui, Amirmohammad
    Alavi, Seyedeh N. R.
    Forouzanfar, Mohammad M.
    Ramawad, Hamzah A.
    Safari, Saeed
    Yousefifard, Mahmoud
    INDIAN JOURNAL OF NEPHROLOGY, 2024, 34 (02) : 144 - 148
  • [9] Prevalence of COVID-19 in Italian Children With Celiac Disease: A Cross-Sectional Study
    Lionetti, Elena
    Fabbrizi, Andrea
    Catassi, Carlo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (05) : 1074 - 1075
  • [10] The prevalence of menstrual changes in COVID-19 vaccinated women: A cross-sectional study
    Safiah, Mhd Homam
    Al Ashabi, Khaled Kalalib
    Khalayli, Naram
    Hodaifa, Yara
    Kudsi, Maysoun
    PREVENTIVE MEDICINE REPORTS, 2024, 44